ClinicalTrials.gov
public full text
Public Domain
Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth. This phase II trial is studying how well lapatinib works in treating patients with recurrent and/or metastatic head and neck cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer#872898
- Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery#833609
- Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#876718
- Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer#904018
- Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer#1087221
Record · ID 859589
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive